Yahoo Movies These are the top 15 richest Canadians in 2018
Latest Stories
- Thomson Reuters StreetEvents
Q3 2024 Lam Research Corp Earnings Call
Q3 2024 Lam Research Corp Earnings Call
Investor's Business DailyDow Jones Futures Dive 400 Points On Weak GDP Data; Meta Plunges On Earnings
Stock Market Today: Dow Jones futures dived 400 points on GDP data. Meta stock plunged on earnings, while Google and Microsoft report next.
- Investor's Business Daily
The Fed's Key Inflation Rate Sizzles As GDP Slows; S&P 500 Futures Slide
The key Federal Reserve inflation rate, the core PCE price index, reared up in Q1 as GDP grew at a slower pace.
- Yahoo Finance
Stock market today: US futures tumble after Meta's reality check, soft GDP print
Meta's AI reality check has dented hopes for a Big Tech revival for stocks, with a GDP update waiting in the wings.
- Reuters
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Rinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent, the study showed. The study is the first head-to-head trial in adults and adolescents with moderate-to-severe atopic dermatitis and had shown an inadequate response to systemic therapy, AbbVie said.
- Associated Press
Belarus claims it prevented drone attacks from Lithuania. Vilnius rejects the allegations
The head of the top security agency in Belarus claimed Thursday that the country has prevented attempted drone strikes from Lithuania that targeted the capital, Minsk, and surrounding areas. Lithuania's military and National Crisis Management Center strongly denied the claim by Ivan Tertel, head of the Belarusian Committee for State Security (KGB).
- Hello!
Shetland’s star new BBC crime thriller sounds brilliant - details
Will you be watching 'The Island'? Find out more about BBC's upcoming drama here
- The Telegraph
China harbours ship transporting North Korean munitions to Russia, satellite images show
China is providing moorage for a US-sanctioned Russian cargo ship implicated in North Korean arms transfers to Russia, according to satellite images.
- Thomson Reuters StreetEvents
Q1 2024 Western Union Co Earnings Call
Q1 2024 Western Union Co Earnings Call
- The Canadian Press
US growth slowed sharply last quarter to 1.6% pace, reflecting an economy pressured by high rates
WASHINGTON (AP) — The nation’s economy slowed last quarter, growing at an annual rate of 1.6% in a sign that the high interest rates may be taking a toll on borrowing and spending. Thursday’s report from the Commerce Department said the gross domestic product — the economy’s total output of goods and services — decelerated from its brisk 3.4% growth rate in the final three months of 2023. Consumers continued to drive growth in the January-March quarter but slowed their spending. Growth was also
- Kansas City Star
Multiple rounds of storms move into Kansas City area. Which days could see severe weather?
Multiple rounds of strong to severe thunderstorms will pass through the Kansas City area the next few days. Here’s what to know about the possibility of severe weather.
- Yahoo News UK
Is UK's worst ever rain linked to 'scary' unexplained warming of Atlantic?
The Atlantic's sea temperature has been getting warmer for 13 months, but scientists don't know why - nor if it's linked to the UK's record wet weather.
- Bears Wire
Caleb Williams’ message for Bears fans before NFL draft: ‘I’m ready to go’
Caleb Williams is just hours away from becoming a Chicago Bear. Here's his message for the fans:
- Reuters
UPDATE 1-Airbus in talks on China jet order ahead of Xi visit, sources say
Airbus is in talks with China over a potentially major aircraft order ahead of a visit to France by Chinese President Xi Jinping, two people familiar with the matter said. The Chinese leader is due to make his first Europe trip in five years next month and diplomatic sources have said trade will be high on the agenda, amid mounting EU-China tensions. China has historically signalled large jet orders timed to coincide with state visits, but the negotiations between Airbus China's CASC buying agency are expected to go down to the wire and are not guaranteed to result in a deal, the people said.
- Yahoo Finance Canada
Taxes 2024: These are some of the benefits parents may be missing
Experts say there are several benefits and credits parents need to be aware of ahead of the April 30 tax deadline.
- Thomson Reuters StreetEvents
Q1 2024 JAKKS Pacific Inc Earnings Call
Q1 2024 JAKKS Pacific Inc Earnings Call
- People
Tiffany Haddish Reveals Painful Endometriosis Battle and 8 Miscarriages: 'The Devil Is Real’ (Exclusive)
The hit comedian and actress gets more candid than ever before about her health ahead of new memoir 'I Curse You With Joy', out May 7
- Insider Monkey
Trustmark Corporation (NASDAQ:TRMK) Q1 2024 Earnings Call Transcript
Trustmark Corporation (NASDAQ:TRMK) Q1 2024 Earnings Call Transcript April 24, 2024 Trustmark Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Trustmark Corporation’s First Quarter Earnings Conference Call. At this time, all […]
- Evening Standard
Venice: Hundreds of Venetians protest as city begins charging day-trippers €5 to enter
Residents fear the scheme will do nothing to reduce tourist numbers, but will turn Venice into ‘a museum, a theme park’
- Reuters
UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and Sanofi's Dupixent in a late-stage head-to-head study. Rinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent, the study showed. The study is the first head-to-head trial in adults and adolescents with moderate-to-severe atopic dermatitis and had shown an inadequate response to systemic therapy, AbbVie said.